Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Ziad Kanaan"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2014 (2014)
Sunitinib malate (Sutent, SU011248) is an oral multitargeted tyrosine kinase inhibitor (TKI) used for the treatment of metastatic renal cell carcinoma and imatinib (Gleevec)—resistant gastrointestinal stromal tumor (GIST) with few reported side eff
Externí odkaz:
https://doaj.org/article/e6edcec96dc0432483b73d71b2b8a6fc
Autor:
Katharina M, Scheurlen, Julia H, Chariker, Ziad, Kanaan, Andrew B, Littlefield, Joan B, George, Caden, Seraphine, Andre, Rochet, Eric C, Rouchka, Susan, Galandiuk
Publikováno v:
Cytokine & Growth Factor Reviews. 67:25-34
The early onset of colorectal cancer (CRC) in individuals younger than 50 years is an emerging phenomenon, and obesity is a strong risk factor. Inflammatory mechanisms are mediated by immune cells, with macrophages and their phenotypical changes play
Publikováno v:
Gastrointestinal Endoscopy. 95:AB181
Autor:
Tooba Tariq, Mohamed E. Awad, Murtaza Hussain, Fadi Antaki, Madison George, Thomas E. Kelly, Fahad S. Ahmed, Furqan B. Irfan, Ziad Kanaan
Publikováno v:
Gastroenterology. 162:S-749
Publikováno v:
Pancreas. 47:e22-e24
Publikováno v:
Textbook of Gastrointestinal Oncology ISBN: 9783030188887
Screening can improve survival for many individuals with premalignant or malignant lesions, particularly those of the gastrointestinal system. The aim of this chapter is to provide a comprehensive review of the most up-to-date recommendations and scr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::650907f36653a06a71285c513c7a2836
https://doi.org/10.1007/978-3-030-18890-0_32
https://doi.org/10.1007/978-3-030-18890-0_32
Autor:
Maurice R Eichenberger, Henry Roberts, Susan Galandiuk, Jianmin Pan, Anna Williford, Shesh N. Rai, Russell W. Farmer, Jeffery Jorden, Norman J. Galbraith, Jane V. Carter, Peter G. Deveaux, Jonathan Rice, James F. Burton, Ziad Kanaan
Publikováno v:
Annals of Surgery. 267:e57-e58
To develop a plasma-based microRNA (miRNA) diagnostic assay specific for colorectal neoplasms, building upon our prior work.Colorectal neoplasms [colorectal cancer (CRC) and colorectal advanced adenoma (CAA)] frequently develop in individuals at ages
Autor:
William G. Cheadle, Rebecca E. Barnett, Robert Keskey, Ziad Kanaan, John M. Rao, Adrian T. Billeter
Publikováno v:
Surgery. 154:521-527
Background Peritonitis is a common cause of surgical sepsis. The failure of the host to mount an appropriate immune response contributes to persistence of the infection. We investigated the role microRNAs may play in this failed immune response. Meth
Autor:
Ziad Kanaan, Surriya Ahmad, Henry Roberts, Tama Thé, Steven Girdler, Jianmin Pan, Shesh N. Rai, E. Brooks Weller, Susan Galandiuk
Publikováno v:
Journal of the National Medical Association. 104:420-427
Objectives: To compare three aspects of Crohn's disease (CD) between African Americans and Caucasians: (1) demographic data and environmental factors affecting CD susceptibility, (2) disease presentation and clinical course, and (3) genetic susceptib
Autor:
Nigel P.S. Crawford, Chris N. Barnes, Shesh N. Rai, Susan Galandiuk, Robert E. Petras, M. Robert Eichenberger, Bobby Keskey, Clayton Weller, Eric Cohen, Amy M. Dworkin, Henry Roberts, Ziad Kanaan
Publikováno v:
Human Mutation. 33:551-560
One of the most serious complications faced by patients with inflammatory bowel disease (IBD) is the potential development of colorectal cancer (CRC). There is a compelling need to enhance the accuracy of cancer screening of IBD patients. MicroRNAs (